Data sources, methods, and limitations
Learn how MediLense prepares FDA FAERS data, links drug labels and clinical trials, checks assistant answers, and explains research limitations.
Where the data comes from
Observed reporting patterns come from FDA FAERS via openFDA. Prescribing label evidence comes from FDA drug labels. Clinical study records come from ClinicalTrials.gov. Drug mechanisms and structures use ChEMBL, PubChem, UniProt, and PDB sources where available.
How to interpret the evidence
Observed reports, prescribing label passages, future reporting forecasts, and trial-context forecasts are different kinds of evidence. MediLense keeps them separate. Counts are deduplicated by report case and latest version; a report can mention more than one medicine and reaction.
Research use
The assistant checks numerical answers against tool results. Forecasts and assistant answers can be wrong. MediLense does not provide medical advice or establish that a medicine is safe.
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.